Last reviewed · How we verify

NCT05623670

Prospective Evaluation of Jugular Vein Thrombi After CPB Cervical Cannulation

Completed Last updated 7 May 2025
What this trial tests

trial testing minimally invasive cardiac surgery using a VJI cannula. in Post-interventional VJI Thrombi After CPB in 44 participants. Completed in 1 April 2025.

Timeline
1 December 2022
Primary endpoint
1 February 2024
1 April 2025

Quick facts

Lead sponsorGoethe University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment44
Start date1 December 2022
Primary completion1 February 2024
Estimated completion1 April 2025
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Goethe University

Who can join

18 and older, any sex, with Post-interventional VJI Thrombi After CPB. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of the study is to prospectively analyse the occurrence of post-interventional internal vena jugularis (VJI) thrombi after minimally invasive cardiac surgery using a VJI cannula to perform cardiopulmonary bypass (CPB). The study follows the question whether the performance of a jugular cannulation for the operation under CPB regularly causes wall thromboses despite continuous anticoagulation and a short length of stay of a few hours. The thromboses to be assessed for the study will be obtained by bedside (Doppler) sonography by experienced intensive care physicians in the cardiac surgery intensive care unit. A prospective analysis of all minimal invasive procedures performed with regard to thrombi in the VJI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Goethe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05623670.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing